Baxter wins antitrust approval for $325 mln Synovis purchase
Medical products maker Baxter has received U.S. regulatory approval for its $325 million acquisition of Synovis Life Technologies, according to a Federal Trade Commission release today.Washington – Medical products maker Baxter...To view the full article, register now.
Already a subscriber? Click here to view full article